Advocacy intelligence hub — real-time data for patient organizations
City of Hope Medical Center — PHASE2
Michael Spinner, MD — PHASE2
University of Cologne — PHASE2
National Research Center for Hematology, Russia — PHASE2
University of Cologne — PHASE2
National Medical Research Radiological Centre of the Ministry of Health of Russia — PHASE2
University of Washington — PHASE2
Akeso — PHASE1, PHASE2
Masonic Cancer Center, University of Minnesota — PHASE2
St. Petersburg State Pavlov Medical University — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Adcetris
(brentuximab vedotin)Orphan drugstandardSeagen Inc.
CD30-directed Immunoconjugate [EPC]
12.1 Mechanism of Action CD30 is a member of the tumor necrosis factor receptor family and is expressed on the surface of sALCL cells and on Hodgkin R...
Ranjana H Advani, MD, MD
Stanford University
📍 STANFORD, CA
Kara M Kelly
Roswell Park Cancer Institute
Alex F Herrera
City of Hope Medical Center
Alison Moskowitz, MD, LCSW
Memorial Sloan Kettering Cancer Center
📍 FAIRFIELD, CT
Antonio Pinto, MD
Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Napoli
Hervé Ghesquières, MD
The Lymphoma Academic Research Organisation